These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3116282)

  • 1. Monocyte cytolytic factor in promoting monocyte-mediated lysis of bladder cancer cells by bacillus Calmette-Guerin.
    Nakamura K; Chiao JW; Nagamatsu GR; Addonizio JC
    J Urol; 1987 Oct; 138(4):867-70. PubMed ID: 3116282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte cytolytic factor in promoting monocyte-mediated lysis of bladder cancer cells by bacillus Calmette-Guerin.
    Catalona WJ
    J Urol; 1987 Oct; 138(4):866. PubMed ID: 3309367
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes.
    Gan C; Amery S; Chatterton K; Khan MS; Thomas K; O'Brien T
    J Urol; 2016 Jun; 195(6):1697-703. PubMed ID: 26845426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer.
    Bockholt NA; Knudson MJ; Henning JR; Maymí JL; Weady P; Smith GJ; Eisenbraun MD; Fraser JD; O'Donnell MA; Luo Y
    J Urol; 2012 Jun; 187(6):2228-35. PubMed ID: 22503050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
    Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
    Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
    Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
    Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.
    Secanella-Fandos S; Noguera-Ortega E; Olivares F; Luquin M; Julián E
    J Urol; 2014 May; 191(5):1422-8. PubMed ID: 24333111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer.
    Niwa N; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Oya M
    J Urol; 2018 Jun; 199(6):1446-1451. PubMed ID: 29307686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells.
    Kim JH; Kim SJ; Lee KM; Chang IH
    BJU Int; 2013 Oct; 112(6):781-90. PubMed ID: 23819923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-mediated cytotoxicity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus Calmette-Guérin.
    Nakamura K
    Keio J Med; 1984 Nov; 33(4):185-99. PubMed ID: 6530875
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of tumor necrosis factor by intravesical administration of bacillus Calmette Guérin in patients with superficial bladder cancer.
    Kim CI; Shin JS; Kim HI; Lee JM; Kim SJ
    Yonsei Med J; 1993 Dec; 34(4):356-64. PubMed ID: 8128741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.
    Hammerstrøm J
    Scand J Immunol; 1979; 10(6):575-84. PubMed ID: 396667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin sensitises fresh transitional carcinoma cells and T24 cell line to non-MHC-restricted cytotoxicity in vitro.
    Kaasinen ES; Kalliomäki PH; Alfthan OS; Timonen TT
    Br J Urol; 1993 Dec; 72(6):897-906. PubMed ID: 8306153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.